Financhill
Back

Co-Diagnostics Stock Predictions

Co-Diagnostics Stock Forecast

  • Is Co-Diagnostics Stock Undervalued?
    The current Co-Diagnostics [CODX] share price is $1.11. The Score for CODX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CODX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Co-Diagnostics Stock Go Up Next Year?

Data Unavailable

Co-Diagnostics Stock Rating

Data Unavailable

Co-Diagnostics Stock Price History

Is CODX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CODX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Medical Devices
Sector:
Healthcare
Type:
stock
Website:
codiagnostics.com

52-Week Data

52-Week High:
1.89
52-Week Low:
0.98

Prediction Charts

Market Cap:
34.7M
Price in USD:
1.11
Volume:
39.61K
Beta:
-0.36

Technical Analysis

SMA50:
1.17
SMA100:
1.22
SMA200:
1.21
52-Wk Change:
-20.71%

Stock Predictions

  • Is Co-Diagnostics stock public?
    Yes, Co-Diagnostics is a publicly traded company.
  • What is the Co-Diagnostics stock quote today?
    The Co-Diagnostics stock price is 1.11 USD today.
  • How to buy Co-Diagnostics stock online?
    You can buy Co-Diagnostics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-8 1.14 1.16 1.23 1.12
Mar-11 1.16 1.14 1.19 1.14
Mar-12 1.15 1.18 1.20 1.15
Mar-13 1.23 1.17 1.23 1.17
Mar-14 1.19 1.19 1.20 1.16
Mar-15 1.13 1.06 1.15 1.06
Mar-18 1.08 1.05 1.14 1.05
Mar-19 1.04 1.10 1.10 1.02
Mar-20 1.09 1.10 1.11 1.07
Mar-21 1.10 1.16 1.18 1.09
Mar-22 1.17 1.17 1.18 1.13
Mar-25 1.15 1.12 1.16 1.10
Mar-26 1.12 1.12 1.12 1.08
Mar-27 1.10 1.11 1.12 1.08

Co-Diagnostics Earnings

Data Unavailable

Co-Diagnostics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.00 per share.

* Co-Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.